Cipla Stock: Cipla is banking on US growth and strong India business. But are the positives priced in its stock?

By admin Dec17,2023

Cipla has become one of the favourite large-cap stocks of investors of late. Since the Covid-19 outbreak in March 2020, the stock has consistently outperformed the benchmark index. Even when many pharma stocks lost steam over the last one year, Cipla’s stock continued to scale new highs. Among large-cap pharma stocks, only Cipla and Sun Pharma have given positive returns in the past one year, driven by an optimistic growth outlook and robust

( Originally published on Oct 13, 2022 )

By admin

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *